Kullanım Kılavuzu
Neden sadece 3 sonuç görüntüleyebiliyorum?
Sadece üye olan kurumların ağından bağlandığınız da tüm sonuçları görüntüleyebilirsiniz. Üye olmayan kurumlar için kurum yetkililerinin başvurması durumunda 1 aylık ücretsiz deneme sürümü açmaktayız.
Benim olmayan çok sonuç geliyor?
Birçok kaynakça da atıflar "Soyad, İ" olarak gösterildiği için özellikle Soyad ve isminin baş harfi aynı olan akademisyenlerin atıfları zaman zaman karışabilmektedir. Bu sorun tüm dünyadaki atıf dizinlerinin sıkça karşılaştığı bir sorundur.
Sadece ilgili makaleme yapılan atıfları nasıl görebilirim?
Makalenizin ismini arattıktan sonra detaylar kısmına bastığınız anda seçtiğiniz makaleye yapılan atıfları görebilirsiniz.
 Görüntüleme 18
 İndirme 3
Evaluation of Maternal and Fetal Outcomes in Intrahepatic Cholestasis of Pregnancy
2020
Dergi:  
Zeynep Kamil Tıp Bülteni
Yazar:  
Özet:

INTRODUCTION: In this study, we aimed to evaluate maternal and fetal outcomes in pregnant women diagnosed with intrahepatic cholestasis of pregnancy (ICP) in our clinic. METHODS: In this retrospective study, we included a total of 53 patients with ICP who were admitted to Bursa Yüksek İhtisas Training and Research Hospital, Obstetrics and Gynecology outpatient clinics between September 2017 and September 2018. The diagnosis of ICP was made based on elevated liver enzymes and bile acids (≥10 μmol/L) and pruritis. Delivery outcomes and demographic characteristics of the patients were obtained from the hospital records. RESULTS: The mean age of the patients was 30.5±5.7 years and the mean gestational age was 32.3±2.8 weeks. The mean bile acid level was 26.42±19.1 μmol/L. Of the patients, 26.4% had gestational diabetes mellitus and 15.1% had preeclampsia. A total of 37.7% of the patients had preterm delivery. Of all neonates, 32.7% required neonatal intensive care unit stay, while 32.7% had transient tachypnea of the newborn and 33.3% had respiratory distress syndrome. No perinatal mortality was observed. DISCUSSION AND CONCLUSION: Our study results suggest that close follow-up and identification of patients with severe cholestasis symptoms are the mainstays of the follow-up of ICP and early treatment to decrease perinatal mortality and morbidity.

Anahtar Kelimeler:

Evaluation of Maternal and Fetal Outcomes in Intrahepatic Cholestasis of Pregnancy
2020
Yazar:  
Özet:

INTRODUCTION: In this study, we aimed to evaluate maternal and fetal outcomes in pregnant women diagnosed with intrahepatic cholestasis of pregnancy (ICP) in our clinic. METHODS: In this retrospective study, we included a total of 53 patients with ICP who were admitted to Bursa Higher Education Training and Research Hospital, Obstetrics and Gynecology outpatient clinics between September 2017 and September 2018. The diagnosis of ICP was made based on elevated liver enzymes and even acids (≥10 μmol/L) and pruritis. Delivery outcomes and demographic characteristics of the patients were obtained from the hospital records. Results: The average age of the patients was 30.5±5.7 years and the average gestational age was 32.3±2.8 weeks. The average even acid level was 26.42±19.1 μmol/L. of the patients, 26. 4% had gestational diabetes mellitus and 15.1% had preeclampsia. A total of 37.7% of the patients had premature delivery. Of all neonates, 32.7% required neonatal intensive care unit stay, while 32.7% had transient tachypnea of the newborn and 33.3% had respiratory distress syndrome. No perinatal mortality was observed. DISCUSION AND CONCLUSION: Our study results suggest that close follow-up and identification of patients with severe cholestasis symptoms are the mainstays of the follow-up of ICP and early treatment to decrease perinatal mortality and morbidity.

Anahtar Kelimeler:

Atıf Yapanlar
Bilgi: Bu yayına herhangi bir atıf yapılmamıştır.
Benzer Makaleler












Zeynep Kamil Tıp Bülteni

Alan :   Sağlık Bilimleri

Dergi Türü :   Ulusal

Metrikler
Makale : 595
Atıf : 350
Zeynep Kamil Tıp Bülteni